Cargando…
Rethinking cost-effectiveness in the era of zero healthcare spending growth
BACKGROUND: The global economic crisis imposes severe restrictions on healthcare budgets, limiting the coverage of new interventions, even when they are cost-effective. Our objective was to develop a tool that can assist decision-makers in comparing the impact of medical intervention alternatives on...
Autores principales: | Arbel, Ronen, Greenberg, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766621/ https://www.ncbi.nlm.nih.gov/pubmed/26911329 http://dx.doi.org/10.1186/s12939-016-0326-8 |
Ejemplares similares
-
Rethinking Aid Allocation: Analysis of Official Development Spending on Modern Pollution Reduction
por: Swinehart, Stephanie, et al.
Publicado: (2019) -
Healthcare spending in the State of Louisiana
por: Kruger, Blake P., et al.
Publicado: (2019) -
Patented Drug Extension Strategies on Healthcare Spending: A Cost-Evaluation Analysis
por: Vernaz, Nathalie, et al.
Publicado: (2013) -
The social determinants of pandemic impact: an opportunity to rethink what we mean by “public health spending”
por: McLaren, Lindsay, et al.
Publicado: (2020) -
Cost and Cost-Effectiveness of a Demand Creation Intervention to Increase Uptake of Voluntary Medical Male Circumcision in Tanzania: Spending More to Spend Less
por: Torres-Rueda, Sergio, et al.
Publicado: (2018)